Free

Prioritisation and evaluation of novel coronavirus diagnostic in the UK

Event Information

Share this event

Date and Time

Location

Location

Online Event

Event description
Learn how the UK is prioritising and evaluating novel Coronavirus IVDs and ensure your diagnostic gets the visibility and support it needs

About this Event

An National Institute for Health Research (NIHR) Industry Webinar: New £1.3 million national research programme to evaluate coronavirus tests in hospitals, GP surgeries and care homes

Determining who has been infected and who currently is infected by coronavirus (SARS-CoV-2) is a key part of the UK’s response to the COVID-19 pandemic. It is therefore imperative that as a nation we can identify the most effective and scalable diagnostics.

During this webinar our experts will describe these efforts in detail, including how new diagnostics are being prioritised and how they will be evaluated through the newly launched £1.3 million national research programme.

Come and join this webinar to listen to our experts and have the opportunity to ask them questions:

Dr Mike Messenger; Deputy Director of the NIHR Leeds MedTech & In-Vitro Diagnostic Co-Operative (MIC) and advisor to the Department of Health and Social Care (DHSC) will describe the various UK initiatives around identifying and prioritising new coronavirus diagnostics.

Professor Richard Body; Director, Manchester Diagnostics and Technology Accelerator and co-Chief Investigator of CONDOR will introduce the new national research programme to ensure novel coronavirus IVDs are evaluated across the UK’s health system.

Dr Joy Allen; Senior Research Associate, Methodologist at Newcastle University will talk about care pathways analysis CONDOR workstream.

Ms Rebecca Albrow; Senior Technical Adviser at NICE will give an update on POC diagnostics for COVID-19 from NICE prospective.

Dr Peter Sargent; Head of Business Development at NIHR Office for Clinical Research Infrastructure will also be on hand to present how NIHR can support diagnostic companies more generally access funding and expert support.

Presentations will be followed by a Q&A session

Share with friends

Date and Time

Location

Online Event

Save This Event

Event Saved